Showing results (271-280 of 318) with videos related to
Sort By:
Pageof 32
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 15, 2001
Alpha-1-antitrypsin and a broad spectrum metalloprotease inhibitor, RS113456, have similar acute anti-inflammatory effectsA Churg, J Dai, K Zay, et al.Drug Delivery and Translational Research|March 20, 2015
Investigation of intrathecal transport of NPT002, a prospective therapeutic based on phage M13, in nonhuman primatesMikhail I Papisov, V Belov, E Belova, et al.Canadian Journal of Surgery. Journal Canadien De Chirurgie|May 1, 1986
Surgical treatment of lung cancer: promise and problems of early diagnosisJ L Wright, C Coppin, B J Mullen, et al.The Journal of Pharmacology and Experimental Therapeutics|July 28, 2011
AZD9668: pharmacological characterization of a novel oral inhibitor of neutrophil elastaseT Stevens, K Ekholm, M Gränse, et al.JSES International|January 26, 2026
Clinical accuracy of humeral and glenoid component placement in total shoulder arthroplasty using ASTRA patient-specific guidesEstelle Wigmore, Joshua G Twiggs, Mark Taylor, et al.Journal of Medicinal Chemistry|December 22, 1995
Identification, characterization and pharmacological profile of three metabolites of (R)-(+)-1,2,3,6-tetrahydro-4-phenyl-1-[(3-phenylcyclohexen-1- yl)methyl]pyridine (CI-1007), a dopamine autoreceptor agonist and potential antipsychotic agentJ L Wright, D M Downing, M R Feng, et al.Prostate Cancer and Prostatic Diseases|April 1, 2015
Metabolic syndrome, dyslipidemia and prostate cancer recurrence after primary surgery or radiation in a veterans cohortL C Macleod, L J Chery, E Y C Hu, et al.Gene Therapy|August 6, 2003
Generating MHC Class II+/Ii- phenotype after adenoviral delivery of both an expressible gene for MHC Class II inducer and an antisense Ii-RNA construct in tumor cellsG G Hillman, N L Kallinteris, J Li, et al.Journal of Medicinal Chemistry|October 14, 1994
The discovery and structure-activity relationships of 1,2,3,6-tetrahydro-4-phenyl-1-[(arylcyclohexenyl)alkyl]pyridines. Dopamine autoreceptor agonists and potential antipsychotic agentsJ L Wright, B W Caprathe, D M Downing, et al.Pharmacology, Biochemistry, and Behavior|February 26, 1998
Pharmacological characterization of PD 152255, a novel dimeric benzimidazole dopamine D3 antagonistA E Corbin, T A Pugsley, H C Akunne, et al.Pageof 32